Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 9/20 | 0.67 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.61 |
| ▸ | HTR2A | P28223 | 1/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.61 |
| ▸ | HRH1 | P35367 | 1/20 | 0.61 |
| ▸ | HTR2B | P41595 | 1/20 | 0.61 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.61 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 7/20 | 0.59 |
| ▸ | ABAT | P80404 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HTR3A | P46098 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL9707013 | 0.90 | BLM (0.68) | ESR1BLMSLC6A2HTR2ASLC6A4 | |
| Acetic Acid SCHEMBL5733361 | 0.90 | BLM (0.68) | ESR1BLMSLC6A2HTR2ASLC6A4 | |
| SCHEMBL5830710 | 0.88 | ESR1 (0.53) | ESR1BLMSLC6A2HTR2ASLC6A4 | |
| SCHEMBL25596196 | 0.82 | BLM (0.63) | ESR1BLMSLC6A2HTR2ASLC6A4 | |
| SCHEMBL25596195 | 0.82 | BLM (0.63) | ESR1BLMSLC6A2HTR2ASLC6A4 | |
| SCHEMBL9583933 | 0.80 | ESR1 (0.59) | ESR1BLMSLC6A2HTR2ASLC6A4 | |
| SCHEMBL25596280 | 0.80 | ESR1 (0.59) | ESR1BLMSLC6A2HTR2ASLC6A4 | |
| SCHEMBL5329248 | 0.80 | ESR1 (0.64) | ESR1BLMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL73405 | 0.80 | ESR1 (1.00) | ESR1BLMSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL228926 | 0.80 | SLC6A2 (0.67) | ESR1BLMSLC6A2HTR2ASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119409579-A | Preparation method of lubabarin key intermediate | 江苏天和制药股份有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-115611752-A | Synthetic refining method of lubabylon intermediate | 江苏天和制药有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-105968302-B | Material and preparation method thereof is combined for ultralow temperature LNG storage tank storage cold insulation polyurethane coating | 江苏长顺高分子材料研究院有限公司 | 2018-09-04 | — | — | CN | claimed |
| CN-103748149-B | Emulsions and their use in the preparation of foams based on isocyanates | 科思创德国股份有限公司 | 2016-08-31 | — | — | CN | claimed |
| CN-103748149-A | Emulsions and their use in the preparation of foams based on isocyanates | BAYER IP GMBH | 2014-04-23 | — | — | CN | claimed |
| CN-101883664-A | The liquid resin composition that is used for abrasive article | SAINT GOBAIN ABRASIVES INC | 2010-11-10 | — | — | CN | claimed |
| CN-101257974-A | Polyisocyanurate rigid foam and process for producing same | BASF SE (DE) | 2008-09-03 | — | — | CN | claimed |
| EP-0145164-B1 | PROCESS FOR IMPROVING MOISTURE RESISTANCE OR EPOXY RESINS BY ADDITION OF CHROMIUM IONS | NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) | 1987-03-04 | — | — | EP | claimed |
| CN-119463302-A | Polypropylene nucleating agent and preparation method and application thereof | 中国石油天然气股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119409579-A | Preparation method of lubabarin key intermediate | 江苏天和制药股份有限公司 | 2025-02-11 | — | — | CN | disclosed |
| US-11970576-B2 | Beta-peptido sugar-copolymer | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2024-04-30 | — | — | US | disclosed |
| CN-115611752-A | Synthetic refining method of lubabylon intermediate | 江苏天和制药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-115611752-A | Synthetic refining method of lubabylon intermediate | 江苏天和制药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| US-20220332892-A1 | BETA-PEPTIDO SUGAR-COPOLYMER | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2022-10-20 | — | — | US | disclosed |
| EP-0014745-B1 | CURING AGENT FOR POLYEPOXIDES, CURABLE EPOXY RESIN COMPOSITIONS, HARDENED PRODUCTS THEREFROM AND PROCESS FOR CURING A POLYEPOXIDE | DIAMOND SHAMROCK CORPORATION (US) | 1983-05-25 | — | — | EP | disclosed |
| US-4336267-A | Heart active compounds and methods of use | AKTIEBOLAGET HASSLE (SE) | 1982-06-22 | — | — | US | disclosed |
| US-4244969-A | (P-HYDROXYPHENOXY)PROPANOLAMINE DERIVATIVES USEFUL AS B-RECEPTOR STIMULANTS | AKTIEBOLAGET HASSLE (SE) | 1981-01-13 | — | — | US | disclosed |
| US-4161542-A | 3-(2-/P-HYDROXYPHENYL/-1-METHYLETHYLAMINO)-1-PHENOXY-2-PROPANOL/; | AKTIEBOLAGET HASSLE (SE) | 1979-07-17 | — | — | US | disclosed |
| US-4148908-A | BRONCHODILATORS | MEAD JOHNSON & COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4055658-A | BETA-ADRENERGIC STIMULANTS, BRONCHIAL | MEAD JOHNSON & COMPANY (US) | 1977-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220332892-A1 | BETA-PEPTIDO SUGAR-COPOLYMER | PBK, PYGB, PDXK | ESR1 3951/4885BLM 2074/4885SLC6A2 2253/4885 |
| US-11970576-B2 | Beta-peptido sugar-copolymer | PBK, PYGB, PDXK | ESR1 3951/4885BLM 2074/4885SLC6A2 2253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.